USP GMP manufacturer bodybuilding pt141 peptide PT 141

USP GMP manufacturer bodybuilding pt141 peptide PT 141

Min.Order / FOB Price:Get Latest Price

1 Gram	FOB Price: USD 70.0000

1 Gram

FOB Price: USD 70.0000

Min.Order :1 Gram
Purity: 99%
Payment Terms : L/C,D/A,D/P,T/T,,MoneyGram,Other

Keywords

PT 141 pt141 peptide pt141

Quick Details

Appearance:White lyophilized powder
Application:Health & Medical & Beauty
PackAge:Foil Bag, According to Client's Requirement
ProductionCapacity:100|Kilogram|Day
Storage:store in cool and dry place
Transportation:FedEx DHL EMS or by Sea

Superiority:

1, High quality with competitive price:

1) Standard:BP/USP/EP/Enterprise standard

2) All Purity≥99%

3) We are manufacturer and can provide high quality products with factory price.

2, Fast and safe delivery

1) Parcel can be sent out in 24 hours after payment.Tracking number available

2) Secure and discreet shipment.Various transportation methods for your choice.

3) Customs pass rate ≥99%

4) We have our own agent/remailer/distributor who can help us ship our products very fast and safe,

and we have stock in there for transferring.

3,We have clients throughout the world.

1) Professional service and rich experience make customers feel at ease, adequate stock and fast delivery meet their desire.

2) Market feedback and goods feedback will be appreciated, meeting customers's requirement is our responsibility.

14) High quality,competitive price,fast delivery ,first-class service gain the trust and praise from the customers.

Details:

USP GMP manufacturer bodybuilding pt141 peptide PT 141

Product Description

Molecular formula: C50H68N14O10
Molar Mass: 1025.2
CAS number: 32780-32-8
PT-141 Structural Names: cyclo-[Nle4, Asp5, D-Phe7, Lys10]alpha-MSH-(4-10)
PT-141 is a metabolite of Melanotan 2

Absrtact Bremelanotide (formerly PT-141) is a compound under drug development by Palatin Technologies as a treatment for female sexual dysfunction, hemorrhagic shock and reperfusion injury. It functions by activating the melanocortin receptors MC1R and MC4R, to modulate inflammation and limitingischemia. It was originally tested for intranasal administration in treating female sexual dysfunctionbut this application was temporarily discontinued in 2008 after concerns were raised over adverse side effects of increased blood pressure. As of March, 2012, Palatin is conducting a human Phase 2B study using a new subcutaneous drug delivery system that appears to have little effect on blood pressure.

OEM SERVICE

CUSTOMIZE THE PRIVATE LABEL AS YOUR REQUIREMENT

1. Supply raw materials and mixed ingredients accodirng to yout formula
2. Make finished products with professional formula, design and other information
3. Different spefications or forms as your requirement, pills, capsules in bottles or packs
4. Print the customized labels and pack products according to your requirements